Submitted by dcc on Thu, 2018-03-01 15:04 Study Title: A Randomized Phase II Trial of Nivolumab, Cabozantinib Plus Nivolumab, and Cabozantinib Plus Nivolumab Plus Ipilimumab in Patients with Previously Treated Non-Squamous NSCLCCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOG-ACRINStatus: ActiveReview Status: Available to Open
